Johnson & Johnson Reports Q4 and Full-Year 2025 Sales Growth, Issues 2026 Guidance

Published on January 22, 2026
NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) yesterday announced fourth-quarter and full-year 2025 financial results, reporting year-over-year fourth quarter sales growth of 9.1 percent to $24.6 billion and full-year reported sales growth of 6.0 percent to $94.2 billion. For the fourth quarter, operational growth was reported at 7.1 percent and adjusted operational growth was 6.1 percent, with full-year operational growth of 5.3 percent and adjusted operational growth of 4.2 percent. Within the company’s MedTech segment, vision grew at a reported 8.9 percent in the fourth quarter, or 6.8 percent operationally, to $1.4 billion. For full-year 2025, vision grew at a reported rate of 6.3 percent or 5.3 percent operationally, to $5.5 billion.
Continue reading on website
Other news

PECAA and VSP Vision Extend Enhanced Vision Exam Rebate Through 2026

January 22, 2026
BOCA RATON, Fla. and RANCHO CORDOVA, Calif—The Professional Eye Care Associates of America (PECAA) and VSP Vision today announced that the limited-time enhancement of the VSP Vision Exam Rebate, which allows PECAA Max members to receive up to $15 per VSP commercial eye exam, has been extended through 2026. The extension that was previously scheduled to end on June 30, 2026, will now continue throu

Heidelberg Engineering Appoints Jeff Sieve as President of Heidelberg Engineering Inc., U.S.

January 22, 2026
FRANKLIN, Mass—Heidelberg Engineering, a provider of ophthalmic imaging and health care data solutions, has announced the appointment of Jeff Sieve as president of Heidelberg Engineering, Inc., U.S., effective January 2026. The company also announced that Ram Liebenthal, who led the U.S. organization as general manager for the past 10 years, is transitioning into a corporate projects leadership ro